
Dr Jacqueline Tearle
Jacqueline completed her Ph.D. at EMBL Australia node in Single Molecule Science, UNSW, under the supervision of A/Prof. Maté Biro, where she used live-cell microscopy and single-cell transcriptomics to investigate cancer cell escape and invasion. She joined Garvan in 2022 as a Postdoctoral Researcher in the Gut Immunogenomics group, led by Dr. Kylie James. Jac’s current research involves using genomic and transcriptiomic approaches to characterise cellular and microbial drivers of intestinal disease. Jac is particularly interested in understanding the impact of modern lifestyle factors on gut health, and is passionate about using this information to develop more relevant therapies, reduce preventable gut pathologies, and support the societal change needed to protect future generations.
Awards
- 2025
ASI MIMS Travel Bursary
- 2025
GESA Mostyn Family Grant
- 2025
GESA Project Grant
- 2024
ASI Postdoctoral Travel Award
- 2024
Tour de Cure Early Career Research Grant
- 2023
EMBL Corporate Partnership Programme Fellowship
- 2023
EMBL Fee Waiver Grant
- 2017
UNSW Tuition Fee Scholarship 2017-2021
- 2015
University of Birmingham Masters Scholarship
- 2012
University of Birmingham Chamberlain Award
Selected publications
See all publications- PUBLISHED 11 August 2023Cancer Research Communications
Targeted Single-cell Isolation of Spontaneously Escaping Live Melanoma Cells for Comparative Transcriptomics
- PUBLISHED 13 November 2023Mucosal Immunology
Role reversals: non-canonical roles for immune and non-immune cells in the gut
- PUBLISHED 5 March 2020Journal of Cell Science
The Lifeact-EGFP mouse is a translationally controlled fluorescent reporter of T cell activation
